FIGURE

Fig. 1

ID
ZDB-FIG-230605-1
Publication
Wu et al., 2022 - Assessment of stromal SCD-induced drug resistance of PDAC using 3D-printed zPDX model chips
Other Figures
All Figure Page
Back to All Figure Page
Fig. 1

Expression patterns and prognosis value of SCD in PDAC samples

(A) Kaplan-Meier curves for OS in TCGA cohort (N = 176) with PDAC based on SCD expression levels.

(B) Correlation between the SCD expression levels and Stromal/Immune Scores (ESTIMATE).

(C) Kaplan-Meier curves for OS in TCGA cohort with PDAC based on SCD expression and stromal score (ESTIMATE).

(D) Kaplan-Meier curves for OS in 31 patients with stroma-enriched PDAC based on SCD expression levels. The differences between the two curves were determined by the log rank (Mantel) test.

(E) Phenotyping of the stroma-enriched PDAC samples, based on the staining of series sections, which were, from left to right, Alcian blue, SCD antibody, Masson staining, Sirius red staining, activated β-catenin antibody, and Hematoxylin. Scale bar: 20 μm. p < 0.05 was considered significant.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ iScience